Pharma Division of Deep Knowledge Analytics has recently launched a new series of proprietary analytics, integrated summaries of which can be reviewed here.

This series currently includes the following 7 reports, which will be updated quarterly and systematically extended by the addition of new special case studies:

– Comparative Industry Analysis and Classification Framework (updated monthly);
– Declining Efficiency of R&D in Pharma Corporations;
– Pharma AI Stock Index;
– Analysis of Leading Investors in the AI for Drug Discovery Sector;
– Top-30 AI-Pharma Analysts;
– Defining Hype vs Reality in AI for Drug Discovery Sector;
– Enhanced Comparative Analysis of Leading AI-startups.

You can read about our analytics methodology here.

We look forward to your feedback, and in case of interest please contact us at

Deep Knowledge Analytics proudly supports the AI Applications in Biopharma Summit.

Confirmed Sponsors


Never miss an announcement